Teva Pharmaceutical Industries Limited News Headlines

TEVA 
$51.14
*  
0.42
0.81%
Get TEVA Alerts
*Delayed - data as of Oct. 17, 2014  -  Find a broker to begin trading TEVA now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
It Is About Time To Prepare Your Portfolio For The Upcoming Bear Market
10/17/2014 10:34:00 AM - Seeking Alpha


With Strong Corporate Partnerships, Xenon Pharmaceuticals IPO Looks Appealing
10/16/2014 9:49:00 PM - Seeking Alpha


IPO Preview: Xenon Pharmaceuticals
10/16/2014 11:43:00 AM - Seeking Alpha


Why Teva Pharmaceutical (TEVA) Stock Is Falling Today
10/15/2014 2:53:00 PM - TheStreet


Investment Strategy: Looking For Long-Term Mega-Trends, Part 1
10/15/2014 12:51:00 PM - Seeking Alpha


Notable Two Hundred Day Moving Average Cross - TEVA
10/13/2014 4:12:55 PM - BNK Invest


Will Johnson & Johnson Beat Earnings on Pharma Sales? - Analyst Blog
10/13/2014 12:50:00 PM - Zacks.com


Royal Bank Of Canada Leads The 20 Best Value Bond Trades With Maturities Of 1 Year Or More
10/13/2014 2:08:00 AM - Seeking Alpha


Momenta Reveals Necuparanib Data for Pancreatic Cancer - Analyst Blog
10/10/2014 4:45:00 PM - Zacks.com


Sector Update: Health Care Stocks Climbing; Alexza Pharmaceuticals, Teva Complete First-Time Stocking of Adusuve in U.S.
10/10/2014 1:08:24 PM - MT Newswires


Sector Update: Health Care
10/10/2014 1:00:41 PM - MT Newswires


Griffin Securities' Keith Markey On The Promise Of RNAi And Synthetic Biologics
10/10/2014 8:54:00 AM - Seeking Alpha


Teva Starts Rolling Submission of its Pain Drug CEP-33237 - Analyst Blog
10/9/2014 4:45:00 PM - Zacks.com


Teva: Overlooked And Potentially Undervalued
10/9/2014 12:07:00 PM - Seeking Alpha


Teva Initiates NDA For CEP -33237, Records Positive Results For Abuse Liability
10/8/2014 8:30:00 AM - RTT News


Teva to Concentrate on Core Specialty Therapeutics - Analyst Blog
10/7/2014 6:09:00 PM - Zacks.com


Mylan Surges on Improved Q3 and Full-Year Earnings Outlook - Analyst Blog
10/6/2014 6:15:00 PM - Zacks.com


BioTime Is Right On Time: Files IND For AMD
10/6/2014 4:32:00 PM - Seeking Alpha


Why Teva Pharmaceuticals (TEVA) Stock Is Falling Today
10/6/2014 2:46:00 PM - TheStreet


Gene therapy biotech Xenon Pharmaceuticals sets terms for $44 million IPO
10/6/2014 9:09:15 AM - Renaissance Capital


Teva Stops R&D In Other Therapeutic Areas, Including Oncology And Women''s Health
10/6/2014 8:50:00 AM - RTT News


Overpriced Expectations: Alcobra Will Get To Second Base, But No Home Run. Options Are Mispriced For An Unlikely Event
9/30/2014 3:03:00 PM - Seeking Alpha


5 Best Stocks to Buy for Q4 and Beyond
9/30/2014 10:36:48 AM - InvestorPlace Media


Comparative Analysis Reveals Undervalued Asset In Antares' Pipeline: First And Only Testosterone Auto-Injector
9/29/2014 6:27:00 PM - Seeking Alpha


High Blood Pressure Is Most Prevalent in These 5 States
9/27/2014 12:34:02 PM - Motley Fool